Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123140) titled 'The Impact of Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Drugs on Renal Function and the Establishment of Risk Models' on April 22.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Shanghai General Hospital

Condition: Drug-induced kidney injury

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-05-01

Target Sample Size: Drug injection group:300;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=293851

Published by HT Digital Content Services with permission from Health Daily Dig...